Vetting companies and new technologies correctly can mean the difference between success and failure for VCs and the C-Suite. In this episode, Adam Torres and Dr. Martin Trevino, Cognitive Neuroscientist & Chief Scientific Advisor, explore what it takes to vet technologies and companies for investment.